Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck: Results of a Phase II multicenter study

Cancer

Volumn 79, Issue 7, 1997, Pages 1394-1400

  Gebbia, Vittorio ^a,g   Mantovani, Giovanni ^b   Farris, Antonio ^c   Agostara, Biagio ^d   Desogus, Alberto ^e   Curreli, Luigi ^b   Moschella, Francesco ^a   Di Gregorio, Carlo ^a   Bajetta, Emilio ^f   Gebbia, Nicolò ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

^d Ospedale Oncologico M Ascoli   (Italy)

^e Ospedale Oncologico A Businco   (Italy)

^f NATIONAL CANCER INSTITUTE   (Italy)

^g Institute of Pharmacology   (Italy)

Author keywords

5 fluorouracil; chemotherapy; cisplatin; head and neck carcinoma; vinorelbine

Indexed keywords

CISPLATIN; FLUOROURACIL; GRANISETRON; GRANULOCYTE COLONY STIMULATING FACTOR; NAVELBINE; ONDANSETRON;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HEAD AND NECK CARCINOMA; HUMAN; HYPOPHARYNX CARCINOMA; INTRAVENOUS DRUG ADMINISTRATION; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OROPHARYNX CARCINOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; VINBLASTINE;

EID: 0030984287     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970401)79:7<1394::AID-CNCR17>3.0.CO;2-V     Document Type: Article

References (25)

1. Al Sarraf M. Head and neck cancer: chemotherapy concepts. Semin Oncol 1988;15:70-85.
2. Clark JR, Frei E III. Chemotherapy for head and neck cancer: progress and controversy in the management of patients with MO disease. Semin Oncol 1989;4:44-57.
3. Clark JR, Dreyfuss AI. The role of cisplatinum in treatment regimens for squamous cell carcinoma of the head and neck. Semin Oncol 1991;18(Suppl 3):34-48.
4. Kish J, Drelichman A, Jacobs J, Hoschner J, Kinzie J, Loh J, et al. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck. Cancer Treat Rep 1982;66:471-4.
5. Kish JA, Weaver A, Jacobs J, Cummings G, Al-Sarraf M. Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 1984;53:1819-924.
6. Vokes EE, Schilsky RL, Weichselbaum RR, Guaspari A, Guarneri CM, Whaling SM, et al. Cisplatin, 5-fluorouracil, and high dose oral leucovorin for advanced head and neck cancer. Cancer 1989;63:1048-53.
7. Dreyfuss AI, Clark JR, Wright JE, Norris CM, Busse PM, Lucarini JW, et al. Continuous infusion high dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. Ann Intern Med 1990;112:167-72.
8. Gebbia V, Testa A, Valenza R, Zerillo G, Cupido G, Ingria F, et al. A Phase II study of levofolinic acid and 5-fluorouracil plus cisplatin in patients with advanced head and neck squamous cell carcinoma. Oncology 1993;50:490-4.
9. Scanlon KJ, Newmann EM, Lu Y, Priest DG. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 1986;83:8923-6.
10. Pfister DG, Strong EW, Harrison L, Haines IE, Pfister DA, Session R, et al. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J Clin Oncol 1991;9:850-9.
11. Vokes EE, Mick R, Lester EP, Panje WR, Weichselbaum RR. Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution. J Clin Oncol 1991;9:1376-84.
12. Cvitkovicz E, Izzo J. The current and future place of vinorelbine in cancer therapy. Drugs 1992;44(Suppl. 4):36-45.
13. Depierre A, Lemarie E, Debuois G, Gamier G, Jacoulet S. Efficacy of navelbine (NVB) in non small cell lung cancer (NCSLC). Semin Oncol 1989:16(Suppl 4):26-9.
14. Fumoleau P, Delgado FM, Delozier T, Monnier A, Delgado G, Kerbrat P, et al. Phase II trial with navelbine (NVB) in advanced breast cancer (ABC): preliminary results. J Clin Oncol 1993;11:1245-52.
15. Gebbia V, Testa A, Valenza R, Zerillo G, Restivo G, Ingria F, et al. A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck. Eur J Cancer 1993;29:1358-9.
16. Marty M, Extra JM, Dieras V, Giacchetti S, Ohana S, Espie M. Review of the antitumor activity of vinorelbine in breast cancer. Drugs 1992;44(Suppl 4):29-35.
17. Smart CR, Rochlin DB, Nahum AM, Silva A, Wagner D. Clinical experience with vinblastine sulphate in squamous cell carcinoma and other malignancies. Cancer Chemother Rep 1964;34:31-5.
18. Haas CD, Fabian CI, Stephens RL, Kish J. Vindesine in head and neck cancer. A Southwest Oncology Group Study. Invest New Drugs 1983;1:339-42.
19. Vogl SE, Carnacho FJ, Kaplan DM, Joss A, Leitner J, Haas AB, et al. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck. Cancer Treat Rep 1984;58:559-60.
20. Popkin JD, Bromer RH, Vaughan CW, Byrne RE III, Licciardello JTW, Hoffer SM, et al. Continuous vindesine infusion in advanced head and neck cancer. Am J Clin Oncol 1983;6:301-4.
21. Leitner SP, Bosl GJ, Strong EW, Gerold FP, Spiro RH, Shah JP, et al. Pilot study of cisplatin-vinblastine as the initial treatment of advanced head and neck cancer. Cancer 1986;58:1014-7.
22. Gebbia V, Testa A, Di Gregorio C, Ingria F, Valenza R, Cannata G, et al. Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neck. Am J Clin Oncol 1995;18:293-6.
23. Gebbia V, Mantovani G, Agostara B, Contu A, Farris A, Colucci G, et al. Treatment of recurrent and/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin, and 5-fluorouracil: a multicenter phase II trial. Ann Oncol 1995;6:987-91.
24. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
25. Palmeri S, Gebbia V, Russo A, Gebbia N, Oliveri D, Rausa L. Cis-diamminodichloroplatinum plus 5-day continuous infusion 5-fluorouracil in the treatment of locally recurrent and metastatic head and neck cancer patients. J Cancer Res Clin Oncol 1989;115:579-82.